2-[4-(2,5-dimethoxyphenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-propylacetamide
Chemical Structure Depiction of
2-[4-(2,5-dimethoxyphenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-propylacetamide
2-[4-(2,5-dimethoxyphenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-propylacetamide
Compound characteristics
Compound ID: | V009-5021 |
Compound Name: | 2-[4-(2,5-dimethoxyphenyl)-1-(4-fluorophenyl)-7-oxo-3-phenyl-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-propylacetamide |
Molecular Weight: | 574.67 |
Molecular Formula: | C31 H31 F N4 O4 S |
Smiles: | CCCNC(CN1C(CSC(c2cc(ccc2OC)OC)c2c(c3ccccc3)nn(c3ccc(cc3)F)c12)=O)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 5.3727 |
logD: | 5.3727 |
logSw: | -5.3215 |
Hydrogen bond acceptors count: | 8 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 69.784 |
InChI Key: | QCPIQWNFECITTE-SSEXGKCCSA-N |